CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Dickson, Tennessee, United States and 401 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Franklin, Tennessee, United States and 260 other locations
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...
Phase 2
Hendersonville, Tennessee, United States and 34 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Franklin, Tennessee, United States and 335 other locations
PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...
Phase 2
Hendersonville, Tennessee, United States and 15 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Nashville, Tennessee, United States and 72 other locations
MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...
Phase 3
Nashville, Tennessee, United States and 121 other locations
This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheez...
Phase 2
Nashville, Tennessee, United States and 38 other locations
This research is being done to test if a drug called omalizumab can help people with Chronic Obstructive Pulmonary Disease (COPD) and allergies.Each...
Phase 2
Nashville, Tennessee, United States and 22 other locations
The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected...
Phase 1
Nashville, Tennessee, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal